Visceral Adipose Remodeling is the complex, dynamic process involving changes in the cellular size, number, and metabolic activity of adipocytes located within the abdominal cavity, surrounding internal organs. Adverse remodeling is characterized by hypertrophy and increased inflammatory cytokine secretion, which is strongly linked to metabolic syndrome and hormonal resistance. Therapeutic interventions aim to shift this remodeling toward smaller, healthier adipocytes with reduced inflammatory output.
Origin
The term combines “visceral adipose,” referring to the metabolically detrimental fat depot around internal organs, with “remodeling,” the structural and functional adaptation of the tissue. This concept is central to understanding the link between fat distribution and cardiometabolic risk.
Mechanism
Remodeling is profoundly influenced by hormonal signaling, particularly insulin and cortisol. Hyperinsulinemia and chronic stress-induced cortisol elevation promote the accumulation and hypertrophy of visceral adipocytes. These dysfunctional cells release pro-inflammatory adipokines, creating a state of chronic low-grade inflammation that drives insulin resistance and compromises endocrine function across multiple axes.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.